Walleye Trading
TAK icon

Walleye Trading’s Takeda Pharmaceutical TAK Stock Holding History

Walleye Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Sell
96,400
-3,200
-3% -$56.2K ﹤0.01% 1788
2025
Q4 		$1.55M Buy
+99,600
New +$1.42M ﹤0.01% 2075
2025
Q2 		– Sell
-26,900
Closed -$400K – 4693
2025
Q1 		$400K Sell
26,900
-14,700
-35% -$206K ﹤0.01% 2663
2024
Q4 		$551K Buy
41,600
+25,800
+163% +$354K ﹤0.01% 2565
2024
Q3 		$225K Sell
15,800
-58,800
-79% -$834K ﹤0.01% 2999
2024
Q2 		$965K Buy
74,600
+15,400
+26% +$204K ﹤0.01% 2096
2024
Q1 		$822K Sell
59,200
-24,100
-29% -$350K ﹤0.01% 2410
2023
Q4 		$1.19M Buy
83,300
+59,200
+246% +$840K ﹤0.01% 2326
2023
Q3 		$373K Buy
24,100
+14,500
+151% +$224K ﹤0.01% 3203
2023
Q2 		$151K Sell
9,600
-14,200
-60% -$233K ﹤0.01% 3572
2023
Q1 		$392K Buy
23,800
+16,600
+231% +$264K ﹤0.01% 2992
2022
Q4 		$112K Sell
7,200
-71,900
-91% -$1M ﹤0.01% 3916
2022
Q3 		$1.03M Buy
79,100
+9,300
+13% +$129K ﹤0.01% 2234
2022
Q2 		$980K Buy
69,800
+57,600
+472% +$822K ﹤0.01% 2243
2022
Q1 		$175K Sell
12,200
-78,600
-87% -$1.15M ﹤0.01% 3902
2021
Q4 		$1.24M Buy
90,800
+15,300
+20% +$215K ﹤0.01% 2043
2021
Q3 		$1.24M Sell
75,500
-78,500
-51% -$1.32M ﹤0.01% 2009
2021
Q2 		$2.59M Sell
154,000
-17,300
-10% -$294K 0.01% 1285
2021
Q1 		$3.13M Buy
171,300
+100,400
+142% +$1.81M 0.01% 979
2020
Q4 		$1.29M Buy
+70,900
New +$1.24M 0.01% 1760
2020
Q1 		– Sell
-992,173
Closed -$19.6M – 4549
2019
Q4 		$19.6M Buy
992,173
+45,600
+5% +$872K 0.14% 125
2019
Q3 		$16.3M Sell
946,573
-223,520
-19% -$3.87M 0.14% 100
2019
Q2 		$20.7M Buy
1,170,093
+211,375
+22% +$3.85M 0.18% 71
2019
Q1 		$19.5M Buy
+958,718
New +$19.3M 0.15% 97

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Trading's TAK Position: Q1 2026 in Review

Walleye Trading sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 27,062 shares — an estimated $475K sold.

Walleye Trading first reported a position in TAK in Q1 2019 and held it in 10 quarters. The position peaked at $17.5M in Q1 2019. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Walleye Trading reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 27,062 Takeda Pharmaceutical shares in Q1 2026, an estimated $475K.
  • Walleye Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 10 quarters.
  • Walleye Trading's Takeda Pharmaceutical position peaked at $17.5M in Q1 2019.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.